Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 3Colonic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Aberrant Crypt Foci 1

Interventions

Fluorouracil 25Oxaliplatin 24Irinotecan 24Leucovorin 23Bevacizumab 23Capecitabine 18Cetuximab 15Radiotherapy 6Gene Expression Profiling 5regorafenib 4Immunohistochemistry 4Gemcitabine 4Folfox protocol 4Colonoscopy 4Cisplatin 4Celecoxib 4Amplified Fragment Length Polymorphism Analysis 4Reverse Transcriptase Polymerase Chain Reaction 3Receptor Protein-Tyrosine Kinases 3Polymerase Chain Reaction 3Nivolumab 3Mitomycin 3Doxorubicin 3Cyclophosphamide 3Cholecalciferol 3Biopsy 3Aspirin 3sargramostim 2pembrolizumab 2ixabepilone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Colonic Neoplasms × Sulindac × Clear all
NCT00062023 2012-07-30

Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer

M.D. Anderson Cancer Center

Phase 2 Terminated
12 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00003365 2011-01-27

Sulindac and Plant Compounds in Preventing Colon Cancer

Rutgers, The State University of New Jersey

Phase NA Terminated
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡